Virtus Investment Advisers’s Meridian Bioscience Inc VIVO Stock Holding History

Virtus Investment Advisers’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,213	Closed	-$273K	–	351
2022 Q4	$273K	Sell	8,213 -3,680	-31%	-$119K	0.18%	160
2022 Q3	$375K	Buy	+11,893	New	+$385K	0.17%	122

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Virtus Investment Advisers's VIVO Position: Q1 2023 in Review

Virtus Investment Advisers sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 8,213 shares — an estimated $273K sold.

Virtus Investment Advisers first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $375K in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Virtus Investment Advisers reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Virtus Investment Advisers sold 8,213 Meridian Bioscience Inc shares in Q1 2023, an estimated $273K.
Virtus Investment Advisers first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Virtus Investment Advisers's Meridian Bioscience Inc position peaked at $375K in Q3 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Virtus Investment Advisers's 13F filing for Q1 2023, filed 15 May 2023.